Cognition Therapeutics, Inc. (CGTX)

NASDAQ: CGTX · IEX Real-Time Price · USD

1.930

-0.050 (-2.53%)

At close: May 3, 2024, 4:00 PM

2.020

+0.090 (4.66%)

After-hours: May 3, 2024, 7:55 PM EDT

Cognition Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	75	56	50	139	-	-
Market Cap Growth	-	11.78%	-63.85%	-	-	-
Enterprise Value	46	27	10	85	8	4
PE Ratio	-2.18	-2.18	-2.35	-8.57	-	-
PB Ratio	3.08	2.30	1.25	2.72	-	-
P/FCF Ratio	-3.48	-3.48	-2.69	-38.07	-	-
P/OCF Ratio	-3.51	-3.51	-2.72	-38.36	-	-
EV/EBITDA Ratio	-1.06	-1.06	-0.46	-7.88	-1.28	-1.07
EV/EBIT Ratio	-1.05	-1.05	-0.45	-7.81	-1.26	-1.05
EV/FCF Ratio	-1.67	-1.67	-0.51	-23.11	-2.23	-1.24
Debt / Equity Ratio	0.03	0.03	0.02	-	-0.19	-0.12
Debt / EBITDA Ratio	-0.03	-0.03	-0.04	-	-2.15	-1.85
Debt / FCF Ratio	-0.04	-0.04	-0.05	-	-3.73	-2.13
Quick Ratio	2.94	2.94	5.33	7.02	1.78	1.18
Current Ratio	3.37	3.37	6.11	7.50	2.13	1.94
Interest Coverage	-954.11	-954.11	-763.18	-12.12	-3.48	-3.73
Return on Equity (ROE)	-83.50%	-83.50%	-49.70%	192.20%	19.10%	-
Return on Assets (ROA)	-63.10%	-63.10%	-39.70%	-49.00%	-165.60%	-
Return on Capital (ROIC)	-201.54%	-201.54%	-105.98%	-55.78%	31.46%	34.61%
Earnings Yield	-34.26%	-45.83%	-42.51%	-11.67%	-	-
FCF Yield	-21.48%	-28.73%	-37.16%	-2.63%	-	-
Buyback Yield / Dilution	-27.03%	-27.03%	-355.42%	-921.60%	66.56%	-
Total Shareholder Return	-27.03%	-27.03%	-355.42%	-921.60%	66.56%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).